Growth-inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement

International Journal of Cancer

Volumn 92, Issue 3, 2001, Pages 354-360

  Greco, A ^a   Roccato, E ^a   Miranda, C ^a   Cleris, L ^a   Formelli, F ^a   Pierotti, M A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

COL1A1 PDGFB rearrangement; Dermatofibrosarcoma protuberans; PDGFB; PDGFr ; STI571; Tumor growth inhibition

Indexed keywords

IMATINIB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; CANCER GRAFT; CANCER INHIBITION; CANCER SURGERY; CHROMOSOME TRANSLOCATION; CULTURE MEDIUM; CYTOTOXICITY; DERMATOFIBROSARCOMA PROTUBERANS; GROWTH INHIBITION; GROWTH RATE; MEDICAL INSTRUMENTATION; MOUSE; NICK END LABELING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; WESTERN BLOTTING;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; DERMATOFIBROSARCOMA; DISEASE MODELS, ANIMAL; GENE REARRANGEMENT; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; ONCOGENE PROTEINS, FUSION; PHOSPHORYLATION; PIPERAZINES; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA;

EID: 0035342499     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1190     Document Type: Article

References (23)

1. Deregulation of the platelet-derived growth factor B-chain gene (PDGBF) via its fusion with the collagen gene (COL1A1) in dermatofibrosarcoma protuberans and giant-cell fibroblastoma
2. Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor B-chain gene in dermatofibrosarcoma protuberans
3. The dermatofibrosarcoma protuberans-associated collagen type Ia1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB
4. Inhibition of the Ab1 protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative
5. Effects of a selective inhibitor of the Ab1 tyrosine kinase on the growth of Bcr-Ab1 positive cells
6. Soft tissue sarcomas in dermatology
7. Pretreatment with intralesional hyaluronidase prior to excision of dermatofibrosarcoma protuberans
8. Adjuvant therapy with hyaluronidase prior to excision of dermatofibrosarcoma protuberans
9. The role of radiation therapy in the management of dermatofibrosarcoma protuberans
10. Ring chromosomes in dermatofibrosarcoma protuberans contain chromosome 17 sequences: Fluorescence in situ hybridization
11. Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: A new tumor-associated chromosome rearrangement
12. CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins
13. + leukemic cells and induces apoptosis
14. In vivo eradication of human BCRABL-positive leukemia cells with an ABL kinase inhibitor
15. TEL/PDGFBR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor
16. UKCCCR guidelines for the welfare of animals in experimental neoplasia
17. K252a inhibits proliferation of glioma cells by blocking platelet-derived growth factor signal transduction
18. Platelet-derived growth factor is an autocrine stimulator for the growth and survival of human esophageal carcinoma cell lines
19. 1
20. NF-κB is a target of AKT in anti-apoptotic PDGF signalling
21. The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth
22. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia
23. Activation of the abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells